1
|
Li E, Knight JM, Wu Y, Luong A, Rodriguez A, Kheradmand F, Corry DB. Airway mycosis in allergic airway disease. Adv Immunol 2019; 142:85-140. [PMID: 31296304 DOI: 10.1016/bs.ai.2019.05.002] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
The allergic airway diseases, including chronic rhinosinusitis (CRS), asthma, allergic bronchopulmonary mycosis (ABPM) and many others, comprise a heterogeneous collection of inflammatory disorders affecting the upper and lower airways and lung parenchyma that represent the most common chronic diseases of humanity. In addition to their shared tissue tropism, the allergic airway diseases are characterized by a distinct pattern of inflammation involving the accumulation of eosinophils, type 2 macrophages, innate lymphoid cells type 2 (ILC2), IgE-secreting B cells, and T helper type 2 (Th2) cells in airway tissues, and the prominent production of type 2 cytokines including interleukin (IL-) 33, IL-4, IL-5, IL-13, and many others. These factors and related inflammatory molecules induce characteristic remodeling and other changes of the airways that include goblet cell metaplasia, enhanced mucus secretion, smooth muscle hypertrophy, tissue swelling and polyp formation that account for the major clinical manifestations of nasal obstruction, headache, hyposmia, cough, shortness of breath, chest pain, wheezing, and, in the most severe cases of lower airway disease, death due to respiratory failure or disseminated, systemic disease. The syndromic nature of the allergic airway diseases that now include many physiological variants or endotypes suggests that distinct endogenous or environmental factors underlie their expression. However, findings from different perspectives now collectively link these disorders to a single infectious source, the fungi, and a molecular pathogenesis that involves the local production of airway proteinases by these organisms. In this review, we discuss the evidence linking fungi and their proteinases to the surprisingly wide variety of chronic airway and systemic disorders and the immune pathogenesis of these conditions as they relate to environmental fungi. We further discuss the important implications these new findings have for the diagnosis and future therapy of these common conditions.
Collapse
Affiliation(s)
- Evan Li
- Department of Medicine, Baylor College of Medicine, Houston, TX, United States
| | - J Morgan Knight
- Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States; Biology of Inflammation Center, Baylor College of Medicine, Houston, TX, United States
| | - Yifan Wu
- Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States
| | - Amber Luong
- Department of Otolaryngology, University of Texas Health Science at Houston, Houston, TX, United States
| | - Antony Rodriguez
- Department of Medicine, Baylor College of Medicine, Houston, TX, United States; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States; Biology of Inflammation Center, Baylor College of Medicine, Houston, TX, United States; Michael E. DeBakey VA Center for Translational Research on Inflammatory Diseases, Houston, TX, United States
| | - Farrah Kheradmand
- Department of Medicine, Baylor College of Medicine, Houston, TX, United States; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States; Biology of Inflammation Center, Baylor College of Medicine, Houston, TX, United States; Michael E. DeBakey VA Center for Translational Research on Inflammatory Diseases, Houston, TX, United States
| | - David B Corry
- Department of Medicine, Baylor College of Medicine, Houston, TX, United States; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States; Biology of Inflammation Center, Baylor College of Medicine, Houston, TX, United States; Michael E. DeBakey VA Center for Translational Research on Inflammatory Diseases, Houston, TX, United States.
| |
Collapse
|
2
|
Garcia M, Le Moal G, Cadranel J, Roblot F, Godet C. Efficacy of nebulized liposomal amphotericin B in the treatment of ABPA in an HIV/HBV co-infected man: Case report and literature review. J Asthma 2018; 56:84-86. [PMID: 29451812 DOI: 10.1080/02770903.2018.1429467] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Magali Garcia
- a Laboratoire de Virologie et Mycobactériologie , CHU Poitiers , Poitiers , France.,b Faculté de Médecine et Pharmacie , Université de Poitiers , Poitiers , France.,c EA 4331, LITEC, Université de Poitiers , Poitiers , France
| | - Gwénaël Le Moal
- d Service de Maladies Infectieuses et Tropicales, CHU Poitiers , Poitiers , France
| | - Jacques Cadranel
- e Service de Pneumologie, AP-HP, Hôpital Tenon, Paris , France.,f Sorbonne Université, UPMC Université Paris , Paris , France
| | - France Roblot
- b Faculté de Médecine et Pharmacie , Université de Poitiers , Poitiers , France.,d Service de Maladies Infectieuses et Tropicales, CHU Poitiers , Poitiers , France.,g Inserm , Poitiers , France
| | - Cendrine Godet
- d Service de Maladies Infectieuses et Tropicales, CHU Poitiers , Poitiers , France
| |
Collapse
|
3
|
Delfino E, Di Biagio A, Giacobbe DR, Viscoli C. Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis. Open Forum Infect Dis 2016; 3:ofw192. [PMID: 27800530 PMCID: PMC5084718 DOI: 10.1093/ofid/ofw192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2016] [Accepted: 08/17/2016] [Indexed: 11/14/2022] Open
Affiliation(s)
- Emanuele Delfino
- Infectious Diseases Division , University of Genoa (Dipartimento di Scienze della Salute) and Istituto di Ricovero e Cura a Carattere Scientifico San Martino-Istituto Scientifico Tumori , Genoa , Italy
| | - Antonio Di Biagio
- Infectious Diseases Division , University of Genoa (Dipartimento di Scienze della Salute) and Istituto di Ricovero e Cura a Carattere Scientifico San Martino-Istituto Scientifico Tumori , Genoa , Italy
| | - Daniele Roberto Giacobbe
- Infectious Diseases Division , University of Genoa (Dipartimento di Scienze della Salute) and Istituto di Ricovero e Cura a Carattere Scientifico San Martino-Istituto Scientifico Tumori , Genoa , Italy
| | - Claudio Viscoli
- Infectious Diseases Division , University of Genoa (Dipartimento di Scienze della Salute) and Istituto di Ricovero e Cura a Carattere Scientifico San Martino-Istituto Scientifico Tumori , Genoa , Italy
| |
Collapse
|